Your browser doesn't support javascript.
loading
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors.
Falchook, G S; Rady, P; Konopinski, J C; Busaidy, N; Hess, K; Hymes, S; Nguyen, H P; Prieto, V G; Bustinza-Linares, E; Lin, Q; Parkhurst, K L; Hong, D S; Sherman, S; Tyring, S K; Kurzrock, R.
Afiliação
  • Falchook GS; Sarah Cannon Research Institute, 1800 Williams Street, Suite 300, Denver, CO, 80218, USA. gerald.falchook@scresearch.net.
  • Rady P; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Konopinski JC; Baylor College of Medicine, Houston, TX, USA.
  • Busaidy N; Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Hess K; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Hymes S; Division of Internal Medicine, Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Nguyen HP; Baylor College of Medicine, Houston, TX, USA.
  • Prieto VG; Division of Pathology and Laboratory Medicine, Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Bustinza-Linares E; Florida Cancer Specialists, Orlando, FL, USA.
  • Lin Q; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Parkhurst KL; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Hong DS; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Sherman S; Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Tyring SK; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Kurzrock R; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Arch Dermatol Res ; 308(5): 357-65, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27098388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Papillomaviridae / Neoplasias Cutâneas / Verrugas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Poliomavírus das Células de Merkel / Imidazóis / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Papillomaviridae / Neoplasias Cutâneas / Verrugas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Poliomavírus das Células de Merkel / Imidazóis / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article